Unique opportunity to acquire a highly specialized aerospace and medical equipment manufacturer in the Northeast

A U.S.-based precision manufacturing platform specializing in high-tolerance components and assemblies for the medical device and aerospace industries is currently exploring a recapitalization to support its next phase of growth. The business operates three advanced production sites on the East Coast with over 70,000 square feet of capacity and more than 100 state-of-the-art CNC and Swiss-turn machining centers. It holds major aerospace and medical certifications, serving a diversified set of established OEM customers. The company produces orthopedic implants and surgical instruments for medical OEMs and tight-tolerance components for commercial and defense aerospace applications. Despite industry-wide headwinds following COVID-related inventory adjustments and medical-sector slowdowns, the company has continued to expand customer relationships and recently secured multiple new program awards with top-tier clients. Revenues over the past few years have fluctuated between $15-$25M USD as the company managed through supply-chain disruptions and customer destocking cycles. For 2025, management projects revenue in the mid-$10-million with a slightly negative EBITDA loss, primarily reflecting temporary volume headwinds. Forecasts indicate a return to positive EBITDA in 2026, supported by already-awarded new programs and a normalization of customer demand in both medical and aerospace markets. The ownership group is evaluating strategic options to recapitalize the business and fund its working-capital needs, while positioning the platform to benefit from ongoing reshoring, OEM outsourcing, and long-term medical device growth trends. A seasoned team with over 50 years of accumulated industry experience from Ex-Toyota Engineers and Ex-McKinsey consultant careers is ready to run a comprehensive due diligence process, confirm the hypotheses for growth, and lead the implementation of the resulting growth plan.